Sitting Pretty in Tough Times

Sitting pretty in tough times Infinity Pharmaceuticals — #1 (Small) By Tia Ghose Courtesy of Infinity Pharma Infinity Pharmaceuticals, an 8-year-old pharmaceutical company in Cambridge, Mass., jumped from fifth place in 2008 to the top spot on our list of best small companies. With an anticancer drug that targets the heat shock promoter 90 (HSP90) in several Phase II clinical trials, and a seven-month-old marriage to Purdue Pharmaceuti

Written byTia Ghose
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

By Tia Ghose

Infinity Pharmaceuticals, an 8-year-old pharmaceutical company in Cambridge, Mass., jumped from fifth place in 2008 to the top spot on our list of best small companies. With an anticancer drug that targets the heat shock promoter 90 (HSP90) in several Phase II clinical trials, and a seven-month-old marriage to Purdue Pharmaceuticals, Infinity is flush with cash—and optimism—when most of the biotech sector is beset by financial woes.

The strategic alliance with Purdue, which involves joint commercialization of new drug targets, provided a fresh infusion of funds. Because of that, "we're expanding right now, in every single department," says Christian Fritz, senior director of the cancer biology group, who has been with Infinity since 2001. The 170-employee company is planning to hire over 30 people in 2009.

Related Articles

Best Places to Work : Industry 2009

Cross-Pollination

Running (RNA) Interference

Back on Top

Survey Methodology

Ranking Tables

Top ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies